Can I Take Green Tea Extract (EGCG) with Lisinopril?

What Is the Interaction Between Green Tea Extract and Lisinopril?

The interaction has two distinct mechanisms: a pharmacodynamic one involving blood pressure, and a pharmacological toxicity concern involving the liver. Lisinopril blocks angiotensin-converting enzyme, reducing angiotensin II and thereby lowering blood pressure. Green tea catechins, especially EGCG, also produce vasodilation through endothelial nitric-oxide pathways, as shown in a 2012 crossover trial (N=14) in which 400 mg EGCG reduced brachial artery systolic pressure by approximately 5 mmHg compared with placebo 1. Combining the two compounds may push blood pressure lower than intended.

The liver concern is separate and does not depend on lisinopril at all. High-dose green tea extract has been classified as a probable cause of drug-induced liver injury (DILI) by the LiverTox database maintained by the National Institutes of Health 2. When a patient on lisinopril also develops hepatotoxicity from EGCG, the clinical picture can be complicated and the cause harder to identify.

Pharmacodynamic: Additive Blood-Pressure Lowering

Lisinopril's antihypertensive effect is well-characterized. In the ATLAS trial, lisinopril at higher doses (32.5 to 35 mg/day) produced sustained systolic reductions in heart failure patients 3. EGCG works through a different but complementary route: it activates endothelial nitric oxide synthase (eNOS) and reduces endothelin-1, both of which relax vascular smooth muscle 4.

A meta-analysis of 20 randomized controlled trials (N=1,536) published in 2014 found that green tea consumption was associated with a mean systolic reduction of 1.94 mmHg (95% CI: 0.98 to 2.89 mmHg, P<0.001) 5. Small numbers can matter when a patient is already at or near their target blood pressure on lisinopril. Symptomatic hypotension, dizziness, and falls are plausible outcomes, especially in patients over 65 or those on diuretics.

Pharmacokinetic: CYP Enzyme Inhibition

At concentrations achievable with high-dose supplements (not brewed tea), EGCG inhibits CYP3A4 and, to a lesser degree, CYP2C9 6. Lisinopril itself is not metabolized by cytochrome P450 enzymes, it is excreted renally unchanged, so a direct CYP-mediated interaction between EGCG and lisinopril is not expected. The clinical relevance of EGCG-driven CYP inhibition is therefore more of a concern if the patient takes other medications metabolized by CYP3A4 (statins, calcium channel blockers) alongside both lisinopril and green tea extract.

How Dangerous Is High-Dose Green Tea Extract to the Liver?

High-dose EGCG supplements carry a genuine hepatotoxicity signal. This risk exists regardless of lisinopril use.

The DILI Evidence

The U.S. Pharmacopeia's Botanical Safety Expert Panel reviewed 34 case reports of liver injury associated with green tea extract products and concluded there was a "probable" causality in a subset of those cases 7. The European Food Safety Authority (EFSA) issued a safety opinion in 2018 concluding that EGCG doses of 800 mg per day or more from supplements "raise safety concerns" for the liver 8. EFSA's opinion specifically called out fasted ingestion as a risk amplifier: taking green tea extract on an empty stomach raises peak EGCG plasma concentrations significantly compared to taking it with food.

The FDA's MedWatch database and the LiverTox resource both list green tea extract as a recognized cause of hepatocellular liver injury, with onset typically within 1 to 3 months of starting the supplement 2.

Why the Liver Risk Matters More on Lisinopril

Lisinopril itself carries a rare but documented risk of cholestatic jaundice and hepatic necrosis, listed in its FDA-approved prescribing information 9. Both compounds can independently stress hepatic function, and combining them raises the theoretical probability that liver enzyme elevations get attributed to the wrong agent, delaying appropriate management.

The HealthRX clinical team uses a tiered risk framework when evaluating this combination:

| EGCG Daily Dose | Risk Category | Recommended Action | |---|---|---| | <200 mg (2 to 3 cups brewed tea) | Low | No special monitoring needed | | 200 to 400 mg (low-dose supplement) | Moderate | Discuss with prescriber; baseline LFTs advisable | | 400 to 800 mg (standard supplement capsule) | High | Prescriber sign-off required; monitor LFTs at 4 and 12 weeks | | >800 mg | Very High | Avoid unless supervised by a hepatologist |

Does Green Tea Extract Affect How Well Lisinopril Works?

Green tea extract does not reduce the efficacy of lisinopril through a pharmacokinetic mechanism, since lisinopril bypasses hepatic metabolism entirely. The concern runs in the other direction: EGCG may amplify the blood-pressure-lowering effect beyond what is therapeutically desirable.

Blood Pressure Monitoring Guidance

The American Heart Association's 2023 hypertension guidance emphasizes that blood pressure targets (typically <130/80 mmHg in most adults) should be achieved without symptomatic episodes of hypotension 10. If EGCG supplements push a patient already at 122/76 mmHg on lisinopril 10 mg below their asymptomatic threshold, the clinical value of the supplement is questionable.

Patients who want to use green tea extract for its antioxidant or metabolic effects may be better served by brewed tea rather than concentrated capsules. A standard cup of green tea contains roughly 100 to 200 mg of total catechins, with EGCG representing 50 to 80% of that fraction. That is a small fraction of what capsule-form products deliver.

Renal Considerations

Lisinopril is prescribed frequently for chronic kidney disease (CKD) because of its renoprotective properties. The 1993 Lewis trial (N=409) established that captopril (a related ACE inhibitor) reduced the risk of doubling serum creatinine by 48% and the combined endpoint of dialysis, transplantation, or death by 50% in type 1 diabetics with nephropathy 11. Similar data exist for lisinopril in CKD.

In patients with CKD, reduced EGCG clearance may increase plasma EGCG exposure, potentially amplifying both the hypotensive and hepatic effects. No dose-adjustment guidance exists for EGCG in CKD, which is itself a reason for caution.

What Does the Research Say About EGCG and Blood Pressure Specifically?

The evidence that EGCG lowers blood pressure is consistent across multiple study designs, even if the magnitude is modest.

Randomized Trial Data

A 2020 systematic review and meta-analysis in the European Journal of Nutrition examined 24 RCTs and found green tea supplementation reduced systolic blood pressure by a mean of 2.1 mmHg (95% CI: 1.0 to 3.2 mmHg) and diastolic blood pressure by 1.7 mmHg (95% CI: 0.9 to 2.5 mmHg) 12. The effect was stronger in studies using EGCG doses above 200 mg per day and in patients with pre-existing hypertension.

That 2.1 mmHg reduction is clinically small in isolation. Combined with lisinopril's typical 10 to 15 mmHg systolic reduction, however, it could push a borderline patient into symptomatic hypotension. This risk is not hypothetical, ACE inhibitor-related hypotension is well-documented in the prescribing literature and is listed as a common adverse event in the CONSENSUS trial of enalapril in severe heart failure 13.

Dietary Tea vs. Supplement Capsules

The pharmacokinetic difference between drinking tea and taking a supplement is not trivial. A 2018 analysis found that peak plasma EGCG concentrations after a single 400 mg supplement dose were approximately 6-fold higher than after drinking 3 cups of green tea containing the same total EGCG content 14. That concentration spike is what drives both the hypotensive effect and the hepatotoxicity signal. Brewed tea, consumed with food, distributes the same catechin load over several hours with far lower peak concentrations.

Who Is at Highest Risk from This Combination?

Some patient profiles face disproportionate risk from combining green tea extract capsules with lisinopril.

High-Risk Populations

Older adults (65 and above) are more susceptible to hypotension-related falls. The CDC estimates that falls cause more than 3 million emergency department visits per year among adults 65 and older in the United States 15. Any additive antihypertensive effect from EGCG supplements in this age group deserves serious consideration.

Patients with liver disease, elevated baseline ALT or AST, or a history of DILI from any prior medication face amplified hepatotoxicity risk. The NIH LiverTox database advises that people with pre-existing liver conditions avoid high-dose green tea extract 2.

Patients on concurrent diuretics (hydrochlorothiazide, furosemide) combined with lisinopril already face a three-way interaction if EGCG is added, since diuretics independently lower blood pressure and reduce intravascular volume.

Lower-Risk Scenario

A generally healthy adult under 60, on a stable lisinopril dose, with normal liver function tests, who drinks 1 to 2 cups of brewed green tea per day rather than taking a supplement capsule, faces a much lower interaction risk. The blood-pressure contribution of brewed tea in this context is small enough that most clinicians would not flag it as a concern, provided the patient's home blood pressure readings remain stable.

Practical Steps If You Are Already Taking Both

If you are currently combining green tea extract capsules with lisinopril, take these steps.

Step 1: Check Your Current Supplement Dose

Look at the supplement label for total EGCG milligrams per serving. Many commercial products deliver 400 to 700 mg EGCG per capsule. If your product exceeds 400 mg per day, that is the EFSA threshold associated with liver safety concerns 8.

Step 2: Measure Your Blood Pressure at Home

Take your blood pressure in the morning before your lisinopril dose and again 2 hours after taking the green tea extract supplement. A drop of more than 20 mmHg systolic between measurements warrants a call to your prescriber.

Step 3: Get Baseline Liver Labs

Ask your prescriber to order ALT, AST, and total bilirubin before continuing the supplement. The American College of Gastroenterology defines significant DILI as an ALT rise above 5 times the upper limit of normal, or a rise above 3 times normal with concurrent jaundice 16. Catching an early rise at 1.5 to 2 times normal allows you to discontinue before injury progresses.

Step 4: Take the Supplement With Food

EFSA's 2018 safety opinion specifically identified fasted ingestion as a risk amplifier for hepatotoxicity 8. Taking green tea extract with a meal reduces peak plasma EGCG concentration and may reduce the risk of liver enzyme elevations, though it does not eliminate the risk at high doses.

Step 5: Report Any Symptoms Promptly

Symptoms such as right-upper-quadrant discomfort, unusual fatigue, dark urine, or yellowing of the skin or eyes require immediate medical evaluation. These are potential signs of hepatotoxicity and should not be watched at home.

What Do Clinical Guidelines Say?

No major hypertension guideline, including the 2023 AHA/ACC Hypertension Guideline or JNC 8, specifically addresses green tea extract coadministration with ACE inhibitors. The absence of a guideline statement does not mean the combination is approved, it reflects a gap in guideline scope, not a finding of safety.

The Natural Medicines comprehensive database (a pharmacist-facing clinical resource) rates the interaction between green tea and antihypertensive drugs as "moderate," noting the risk of additive blood-pressure lowering and advising monitoring 17. The prescribing information for lisinopril advises caution with any agent that can further reduce blood pressure, including diuretics and other antihypertensives 9.

The United States Pharmacopeia's guidance on green tea safety states: "Consumers should be aware that concentrated green tea extracts can cause liver damage in rare cases, and that the risk may be higher in people taking other medications that affect the liver" 7.